Prevalence and 20-year epidemiological trends of glomerular diseases in the adult Saudi population: a multicenter study

Talal AlFaadhel,Abdulkareem Alsuwaida,Khaled Alsaad,Lamees Almezaini,Noura Ahmed,Mahmoud Yassin AlHamad,Ammar Bakheet,Junaid Wadera,Ghadeer Mokhtar,Feras Alsuwaida,Rehan Siddiqui,Mohamed Kechrid,Ashraf Abdelrehman,Sufia Husain,Hala Kfoury,Abdulrahaman Alabdulsalam,Majed Alanazi,Noura Al Oudah,Hanadi AlHozali
DOI: https://doi.org/10.5144/0256-4947.2019.155
Abstract:Background: Recent international reports have shown significant changes in the incidence of different glomerular diseases. Objective: Examine temporal and demographic trends of biopsy-diagnosed glomerular diseases in the adult population of Saudi Arabia over the last two decades. Design: Medical record review. Settings: Four tertiary medical centers in Saudi Arabia. Patients and methods: We identified all patients that underwent native kidney biopsy between 1998 and 2017. Main outcome measures: The frequency and the disease trends in four biopsy eras (1998-2002, 2003-2007, 2008-2011, and 2012-2017) for different glomerular diseases. Sample size and characteristics: 1070 patients, 18-65 years of age; 54.1% female. Results: Of 1760 patients who underwent native kidney biopsies, 1070 met inclusion criteria. Focal segmental glomerulosclerosis was the most common biopsy-diagnosed disease, with comparable frequencies over the four eras (23.6%, 19.8%, 24.1%, and 17.1, respectively [ P value for trend=.07]). The frequency of immunoglobulin A nephropathy increased progressively. The incidence of membranoproliferative glomerulonephritis declined significantly. Among the secondary types of glomerular diseases, systemic lupus erythematosus-associated lupus nephritis was the most common, followed by diabetic nephropathy. The prevalence of diabetic nephropathy increased from 1.4% in the first era to 10.2% in the last one. Conclusions: Trends in biopsy-diagnosed glomerular disease have changed. While focal segmental glomerulosclerosis remains the most common glomerular disease, there has been a significant rise in the prevalence of immunoglobulin A nephropathy and diabetic nephropathy. In contrast, membranoproliferative glomerulonephritis has declined. Limitations: Retrospective methodologies are vulnerable to lost data. Conflict of interest: None.
What problem does this paper attempt to address?